GET THE APP

Chemotherapy: Open Access

Chemotherapy: Open Access
Open Access

ISSN: 2167-7700

+44 1223 790975

Nathan R. Wall

Nathan R. Wall

Nathan R. Wall interim Chief Executive Officer (CEO) of Canget USA

Biography
Nathan R. Wall, PhD, MBA, MS - Dr. Wall is the acting interim Chief Executive Officer (CEO) of Canget. As interim CEO, Dr. Wall's primary responsibility is to tell our story to potential investors and partners, a role he takes very seriously. Dr. Wall has tremendous experience and standing in the cancer field and is an expert in the cancer cell death inhibitor Survivin and its role in modulating the tumor microenvironment. In 2005, with an 8.5 million dollar NIH grant that Dr. Wall and four of his colleagues were awarded, Dr. Wall and his colleagues founded the Center for Health Disparities and Molecular Medicine at Loma Linda University. The Center's mission is to eliminate health disparities through research, education, and community engagement. Dr. Wall obtained outstanding post-doctoral biomedical and molecular training at prestigious institutions such as Yale University and Harvard Medical School. He graduated with his PhD from the first Cancer Biology Graduate Program in the United States at Wayne State University's Karmanos Cancer Institute and Michigan Cancer Foundation. After being highly recruited to Loma Linda University's School of Medicine, he went on to complete his Master's in Business Administration at the University of Redlands where he serves on the Alumni Board of Director's and he is currently working towards his Master's degree in Public Health. Dr. Wall is an active volunteer in both professional and civic arenas. He currently serves proudly in the California Army National Guard where he has rose to the rank of Captain and Company Commander of the states' Medical Command. He was recently awarded the Army Achievement Medal (AAM). He and his wife Jill have recently adopted 5 children from their local area and are active in all things that 4, 5, 10, 12 and 15 year olds can get into. Research interest include investigate the contribution extracellular (exosomal) survivin makes to the resistance of cancers to stress-induced cell death in the tumor microenvironment. Nathan has over peer reviewed 74 publication.
Research Interest

interest include investigate the contribution extracellular (exosomal) survivin makes to the resistance of cancers to stress-induced cell death in the tumor microenvironment.

Relevant Topics

Top